709 filings
Page 3 of 36
8-K
cr7qq k45t6tji
27 Sep 22
New branding reflects Company’s vision to be the leader in the treatment of Stress Urinary Incontinence in Women
8:29am
CORRESP
wwc 20urf
26 Sep 22
Correspondence with SEC
12:00am
8-K
cjmnoo bod
22 Sep 22
Viveve to Participate in Ladenburg Thalmann Healthcare Conference
8:29am
8-K
oh93y4di
15 Sep 22
Viveve to Participate in Alliance Global Partners Virtual MedTech Conference
8:29am
8-K
i52w0
1 Sep 22
Viveve to Participate in H.C. Wainwright 24th Annual Global Investment Conference
8:29am
8-K
7j8ipu
11 Aug 22
Viveve Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:08pm
8-K
jht1dscw
12 Jul 22
Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
8:29am
8-K
16adhd2xppolgojjx
3 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
tx9vfoqw26s1
17 May 22
Viveve to Participate in H.C. Wainwright Global Investment Conference
4:29pm
8-K
ogrxyudu06az5x1u e2
12 May 22
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:03pm
8-K
t684gog i32qsmwa3m
9 May 22
Submission of Matters to a Vote of Security Holders
12:00am
8-K
e6vlvs v9t67mv1ef
17 Mar 22
Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
d9luqs1xxe6hth2
21 Jan 22
Departure of Directors or Certain Officers
4:15pm
S-8
dl8o8
5 Jan 22
Registration of securities for employees
12:00am
8-K
7nsn9yh66u744
14 Dec 21
Viveve Announces Completion of Full Enrollment in Pivotal U.S. PURSUIT Trial for Stress Urinary Incontinence
8:29am